Koki Maeda, Nobuhiro Imamura, Keisuke Tabata, Shoichiro Morizono, Takuya Tokunaga, Aya Takeda, Go Kamimura, Oniwa Masashi, Keiko Mizuno, Masaya Aoki, Kazuhiro Ueda
{"title":"SF<sub>6</sub> is a useful expander for post-pneumonectomy syndrome in the long-term course: a case report.","authors":"Koki Maeda, Nobuhiro Imamura, Keisuke Tabata, Shoichiro Morizono, Takuya Tokunaga, Aya Takeda, Go Kamimura, Oniwa Masashi, Keiko Mizuno, Masaya Aoki, Kazuhiro Ueda","doi":"10.1186/s40792-024-01972-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-pneumonectomy syndrome (PPS) is a rare but serious condition that can occur after pneumonectomy. It is characterized by a mediastinal shift towards the vacated hemithorax, which can potentially lead to respiratory failure. The management of PPS poses a clinical challenge, especially in the context of the limited availability of certain therapeutic devices due to regulatory restrictions in Japan.</p><p><strong>Case presentation: </strong>A 36-year-old female with stage IB non-small cell lung cancer underwent left pneumonectomy. Approximately 2 years later, she developed dyspnea. After consulting with our hospital, subsequent imaging revealed an extreme mediastinal shift causing bronchial obstruction. Emergency thoracotomy and subsequent sulfur hexafluoride (SF<sub>6</sub>) injections were successfully used to manage her condition. Over the course of follow-up, the interval between SF<sub>6</sub> injections was extended from 3 to 11 months, indicating an improvement in the intrathoracic condition.</p><p><strong>Conclusions: </strong>This case illustrates the efficacy of SF<sub>6</sub> gas in treating PPS and in reducing the frequency of medical interventions. SF<sub>6</sub> gas administration is safe and effective for the treatment of patients with PPS.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254868/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40792-024-01972-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Post-pneumonectomy syndrome (PPS) is a rare but serious condition that can occur after pneumonectomy. It is characterized by a mediastinal shift towards the vacated hemithorax, which can potentially lead to respiratory failure. The management of PPS poses a clinical challenge, especially in the context of the limited availability of certain therapeutic devices due to regulatory restrictions in Japan.
Case presentation: A 36-year-old female with stage IB non-small cell lung cancer underwent left pneumonectomy. Approximately 2 years later, she developed dyspnea. After consulting with our hospital, subsequent imaging revealed an extreme mediastinal shift causing bronchial obstruction. Emergency thoracotomy and subsequent sulfur hexafluoride (SF6) injections were successfully used to manage her condition. Over the course of follow-up, the interval between SF6 injections was extended from 3 to 11 months, indicating an improvement in the intrathoracic condition.
Conclusions: This case illustrates the efficacy of SF6 gas in treating PPS and in reducing the frequency of medical interventions. SF6 gas administration is safe and effective for the treatment of patients with PPS.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
